trans Palmitoleic acid arises endogenously from dietary vaccenic acid 1 – 3

Background: trans Palmitoleic acid (t-16:1n–7, or 16:1t9 in the d nomenclature usually applied to trans fatty acids and used herein) arouses great scientific interest because it has been suggested to serve as a biomarker for lower risks of type 2 diabetes and coronary artery disease. Objective: Although 16:1t9 has been assumed to derive from dietary sources, we examined the hypothesis that 16:1t9 might also be endogenously produced from its metabolic precursor vaccenic acid (t-18:1n–7 or 18:1t11). Design: We reevaluated fatty acid data obtained from one human intervention study and one cellular model in both of which 18:1t11 was supplemented. Both studies have already been published, but to our knowledge, 16:1t9 has not yet been considered. This reanalysis of the datasets was reasonable because a new methodology for identifying 16:1 cis and trans isomers allowed us to address the subject presented in this article. Results: Data showed that the systemic or intracellular increase in 16:1t9 was strongly correlated with the increase in 18:1t11 after the dietary intake or cellular uptake of 18:1t11. The conversion rate in humans was, on average, 17%. Conclusion: Our findings suggest that endogenous 16:1t9 is not, as has been assumed, exclusively diet derived but may also be produced by the partial b oxidation of dietary 18:1t11. Am J Clin Nutr 2014;99:431–5.